These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 35229906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti-TNF therapy in a tuberculosis endemic region.
    Ye L, Chapman TP, Wen Z, Lin L, Qiu Y, Liu Z, Ran Z, Qian J, Wu K, Gao X, Hu P, Chen M, Travis SPL, Cao Q, Chinese IBD Elite Union.
    Aliment Pharmacol Ther; 2021 Feb; 53(3):390-399. PubMed ID: 33314259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
    Sugiyama Y, Ueno N, Tachibana S, Kobayashi Y, Murakami Y, Sasaki T, Sakatani A, Takahashi K, Ando K, Kashima S, Moriichi K, Tanabe H, Okumura T, Fujiya M.
    Medicine (Baltimore); 2023 Jul 14; 102(28):e34331. PubMed ID: 37443475
    [Abstract] [Full Text] [Related]

  • 7. The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy.
    Mantzaris GJ, Tsironikos D, Tzanetakou X, Grispou E, Karatzas P, Kalogeropoulos I, Papamichael K.
    Scand J Gastroenterol; 2015 Jul 14; 50(12):1451-5. PubMed ID: 26139305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF, Viegas ERC, Carneiro AJV, Esberard BC, Chinem ES, Correa RS, Rodrigues L, Ribeiro-Alves M, Silva KS, de Souza HS, Carvalho ATP.
    Dig Dis Sci; 2019 Jul 14; 64(7):1916-1922. PubMed ID: 30673986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
    Hatzara C, Hadziyannis E, Kandili A, Koutsianas C, Makris A, Georgiopoulos G, Vassilopoulos D.
    Ann Rheum Dis; 2015 Oct 14; 74(10):1848-53. PubMed ID: 24854354
    [Abstract] [Full Text] [Related]

  • 15. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Hou JK, Kramer JR, Richardson P, Sansgiry S, El-Serag HB.
    Inflamm Bowel Dis; 2017 Feb 14; 23(2):254-260. PubMed ID: 27997433
    [Abstract] [Full Text] [Related]

  • 16. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW, Hong Y, Jung YJ, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Lee SD, Kim WS, Kim DS, Shim TS.
    Respir Med; 2013 Nov 14; 107(11):1797-802. PubMed ID: 24029000
    [Abstract] [Full Text] [Related]

  • 17. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Al-Taweel T, Strohl M, Pai M, Martel M, Bessissow T, Bitton A, Seidman E, Afif W.
    Dig Dis Sci; 2018 Oct 14; 63(10):2695-2702. PubMed ID: 29968143
    [Abstract] [Full Text] [Related]

  • 18. Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients.
    Wong SH, Ip M, Tang W, Lin Z, Kee C, Hung E, Lui G, Lee N, Chan FK, Wu JC, Sung JJ, Ng SC.
    Inflamm Bowel Dis; 2014 Nov 14; 20(11):2067-72. PubMed ID: 25159454
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC, Jo KW, Jung YJ, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Shim TS.
    Scand J Infect Dis; 2014 Nov 14; 46(11):763-9. PubMed ID: 25195652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.